Ginko International Co., Ltd., together with its subsidiaries, manufactures and sells non-disposable and disposable contact lenses, and lens care products in China, Germany, the United Kingdom, Australia, Poland, Canada, Brazil, Iran, and internationally.
Ginko International Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$207.00|
|52 Week High||NT$125.00|
|52 Week Low||NT$300.00|
|1 Month Change||1.47%|
|3 Month Change||-20.39%|
|1 Year Change||53.33%|
|3 Year Change||8.40%|
|5 Year Change||-30.11%|
|Change since IPO||-2.75%|
Recent News & Updates
|8406||TW Medical Equipment||TW Market|
Return vs Industry: 8406 exceeded the TW Medical Equipment industry which returned 10.8% over the past year.
Return vs Market: 8406 exceeded the TW Market which returned 39% over the past year.
Stable Share Price: 8406 is more volatile than 90% of TW stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: 8406's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
Ginko International Co., Ltd., together with its subsidiaries, manufactures and sells non-disposable and disposable contact lenses, and lens care products in China, Germany, the United Kingdom, Australia, Poland, Canada, Brazil, Iran, and internationally. The company offers various optical products, such as high definition contact lenses, toric lenses, cosmetic lenses, and others, as well as lens solutions under the Horien and Hydron brands. Ginko International Co., Ltd.
Ginko International Fundamentals Summary
|8406 fundamental statistics|
Is 8406 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|8406 income statement (TTM)|
|Cost of Revenue||NT$4.02b|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||14.38|
|Net Profit Margin||16.22%|
How did 8406 perform over the long term?See historical performance and comparison
2.9%Current Dividend Yield
Is Ginko International undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 8406 (NT$207) is trading below our estimate of fair value (NT$295.38)
Significantly Below Fair Value: 8406 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 8406 is good value based on its PE Ratio (14.4x) compared to the TW Medical Equipment industry average (23.3x).
PE vs Market: 8406 is good value based on its PE Ratio (14.4x) compared to the TW market (16.4x).
Price to Earnings Growth Ratio
PEG Ratio: 8406 is poor value based on its PEG Ratio (1.1x)
Price to Book Ratio
PB vs Industry: 8406 is good value based on its PB Ratio (1.7x) compared to the TW Medical Equipment industry average (2x).
How is Ginko International forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 8406's forecast earnings growth (12.6% per year) is above the savings rate (0.8%).
Earnings vs Market: 8406's earnings (12.6% per year) are forecast to grow faster than the TW market (8.5% per year).
High Growth Earnings: 8406's earnings are forecast to grow, but not significantly.
Revenue vs Market: 8406's revenue (9.5% per year) is forecast to grow slower than the TW market (9.5% per year).
High Growth Revenue: 8406's revenue (9.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 8406's Return on Equity is forecast to be low in 3 years time (12.3%).
How has Ginko International performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 8406 has high quality earnings.
Growing Profit Margin: 8406's current net profit margins (16.2%) are higher than last year (13.4%).
Past Earnings Growth Analysis
Earnings Trend: 8406's earnings have declined by 6.4% per year over the past 5 years.
Accelerating Growth: 8406's earnings growth over the past year (37.1%) exceeds its 5-year average (-6.4% per year).
Earnings vs Industry: 8406 earnings growth over the past year (37.1%) exceeded the Medical Equipment industry 9.5%.
Return on Equity
High ROE: 8406's Return on Equity (12.1%) is considered low.
How is Ginko International's financial position?
Financial Position Analysis
Short Term Liabilities: 8406's short term assets (NT$13.9B) exceed its short term liabilities (NT$6.4B).
Long Term Liabilities: 8406's short term assets (NT$13.9B) exceed its long term liabilities (NT$4.5B).
Debt to Equity History and Analysis
Debt Level: 8406's debt to equity ratio (75.6%) is considered high.
Reducing Debt: 8406's debt to equity ratio has increased from 46.3% to 75.6% over the past 5 years.
Debt Coverage: 8406's debt is well covered by operating cash flow (29.9%).
Interest Coverage: 8406's interest payments on its debt are well covered by EBIT (42.3x coverage).
What is Ginko International current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 8406's dividend (2.9%) is higher than the bottom 25% of dividend payers in the TW market (1.95%).
High Dividend: 8406's dividend (2.9%) is low compared to the top 25% of dividend payers in the TW market (5.27%).
Stability and Growth of Payments
Stable Dividend: 8406 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 8406's dividend payments have increased, but the company has only paid a dividend for 8 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (41.7%), 8406's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: 8406's dividends in 3 years are forecast to be covered by earnings (57.8% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ginko International has no CEO, or we have no data on them.
Experienced Management: 8406's management team is seasoned and experienced (13 years average tenure).
Experienced Board: 8406's board of directors are considered experienced (7.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Ginko International Co., Ltd.'s employee growth, exchange listings and data sources
- Name: Ginko International Co., Ltd.
- Ticker: 8406
- Exchange: TPEX
- Founded: 2007
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: NT$20.191b
- Shares outstanding: 97.07m
- Website: https://www.ginkointernational.com
Number of Employees
- Ginko International Co., Ltd.
- Grand Pavilion
- Hibiscus Way
- Grand Cayman
- Grand Cayman
- Cayman Islands
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/24 15:39|
|End of Day Share Price||2021/09/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.